Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
GENERATIVE AI SOL | N8T | Sep 19, 2024 | 0.09 | +13.16 |
Generic Gold Corp | 1WD | Sep 19, 2024 | 0.01 | 0.00 |
Genertec Universal Medical Group Company Limited | 5UM | Sep 19, 2024 | 0.45 | +1.36 |
Genesco Inc. | GN8 | Sep 19, 2024 | 25.20 | +5.00 |
GENESIS AI CORP. | NL8 | Sep 19, 2024 | 0.02 | -14.68 |
Genetic Analysis | 8V8 | Sep 19, 2024 | 0.04 | -22.00 |
Genetic Technologies ADR | DU80 | Sep 19, 2024 | 0.70 | -2.10 |
Genetic Technologies Ltd. | DU8 | Sep 19, 2024 | 0.02 | -5.26 |
GeNeuro SA | GEM | Sep 19, 2024 | 0.04 | -14.22 |
Genfit | XUP | Sep 19, 2024 | 3.90 | +2.36 |
GENFIT S.A. - American Depositary Shares | XUPB | Sep 19, 2024 | 3.70 | +1.65 |
Genflow Biosciences Plc | WQ5 | Sep 19, 2024 | 0.02 | 0.00 |
Genie Energy Ltd. Class B | 6GE | Sep 19, 2024 | 15.30 | +2.00 |
GENinCode plc | 9PL | Sep 19, 2024 | 0.08 | 0.00 |
Genius Metals Inc. | 0FU | Sep 19, 2024 | 0.05 | -7.07 |
Genmab | GE9 | Sep 19, 2024 | 236.70 | -0.13 |
Genmab A/S - American Depositary Shares | GE91 | Sep 19, 2024 | 23.00 | -1.71 |
Genomma Lab Internacional SAB | GEKA | Sep 19, 2024 | 0.94 | -2.07 |
Genomtec S.A. | 4VI | Sep 19, 2024 | 1.45 | -1.76 |
Genor Biopharma Holdings Limited | 67N0 | Sep 19, 2024 | 0.17 | 0.00 |
Genovis | 5GV | Sep 19, 2024 | 1.97 | +0.41 |
Genoway | JEH | Sep 19, 2024 | 3.58 | +0.85 |
Genpact Ltd | 35G | Sep 19, 2024 | 34.30 | +0.09 |
Genscript Biotech Corporation | G51 | Sep 19, 2024 | 1.35 | -2.17 |
GenSight Biologics S.A. | G49N | Sep 19, 2024 | 0.34 | -1.62 |
Gensource Potash Corp | UGN | Sep 19, 2024 | 0.05 | -6.25 |
Gentex Corporation | GTX | Sep 19, 2024 | 26.40 | 0.00 |
Gentherm Inc | QA4A | Sep 19, 2024 | 44.20 | +1.38 |
Gentian Diagnostics | 6FK | Sep 19, 2024 | 4.02 | +5.24 |
GENTILI MOSCONI S.P.A | Z5A | Sep 19, 2024 | 2.42 | +0.41 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.